At what Hemoglobin A1c (HbA1c) level can diabetes be diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Diabetes Using HbA1c

Diabetes can be definitively diagnosed with an HbA1c value of ≥6.5% (≥48 mmol/mol) when measured using a standardized, NGSP-certified laboratory method. 1

Diagnostic Criteria for Diabetes

The American Diabetes Association (ADA) has established the following diagnostic criteria for diabetes:

  • HbA1c ≥6.5% (≥48 mmol/mol) using a method that is NGSP certified and standardized to the DCCT assay 1
  • Fasting plasma glucose (FPG) ≥126 mg/dL (7.0 mmol/L) after at least 8 hours of fasting 1
  • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (OGTT) 1
  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) in patients with classic symptoms of hyperglycemia or hyperglycemic crisis 1

Confirmation Requirements

Unless there is a clear clinical diagnosis (e.g., patient with hyperglycemic crisis or classic symptoms with random glucose ≥200 mg/dL), a second test is required for confirmation 1:

  • Ideally, the same test should be repeated for confirmation
  • If two different tests (e.g., HbA1c and FPG) are both above diagnostic thresholds, this also confirms the diagnosis
  • When results are discordant, the test that is above the diagnostic threshold should be repeated

Advantages of Using HbA1c for Diagnosis

  • Greater convenience (no fasting required)
  • Better preanalytical stability
  • Less day-to-day perturbations during periods of stress and illness 1
  • Reflects average glycemia over the preceding 60-90 days 1

Limitations and Precautions

HbA1c testing should not be used for diagnosis in the following situations:

  • Conditions with abnormal red blood cell turnover:
    • Pregnancy (second and third trimesters)
    • Hemolytic anemia
    • Recent blood loss or transfusion
    • Hemodialysis
    • Erythropoietin therapy 1
  • Hemoglobinopathies (use assays without interference or use glucose criteria instead)
  • Marked discordance between measured A1C and plasma glucose levels 1

Prediabetes Classification

Individuals with HbA1c levels between 5.7% and 6.4% (39-46 mmol/mol) are classified as having prediabetes 1, 2:

  • HbA1c 5.7-6.0%: 3-8 fold increased risk of developing diabetes 2
  • HbA1c 6.0-6.4%: approximately 20 times higher risk of developing diabetes 2

Testing Considerations

  • Only NGSP-certified methods should be used for diagnosis 1
  • Point-of-care HbA1c testing should not be used for diagnosis unless using FDA-approved devices at CLIA-certified laboratories that perform testing of moderate complexity or higher 1
  • Laboratory standardization is critical for accurate diagnosis 1

Clinical Pearls

  • The HbA1c cut-off of 6.5% has high specificity but lower sensitivity compared to glucose-based criteria 3
  • When using HbA1c for diagnosis, approximately one-third fewer cases of undiagnosed diabetes are identified compared to using fasting glucose criteria 1
  • However, the greater convenience of HbA1c testing may lead to wider application and potentially increase the overall number of diagnoses 1
  • Marked discrepancies between measured HbA1c and plasma glucose levels should prompt consideration that the HbA1c assay may not be reliable for that individual 1

By understanding these diagnostic criteria and their limitations, clinicians can appropriately diagnose diabetes using HbA1c while recognizing situations where glucose-based testing may be more appropriate.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prediabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.